ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
WelshBuffett
|
156 |
41K |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
156
|
41K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
486K |
4 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
1.6K
|
486K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIOTRON CLINICAL TRIAL RESULTS WEBINAR
|
|
WelshBuffett
|
151 |
42K |
4 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
151
|
42K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
The Final Countdown
|
|
WelshBuffett
|
225 |
59K |
11 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
225
|
59K
|
11
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
31K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
115
|
31K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
The Final Countdown
|
|
WelshBuffett
|
225 |
59K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
225
|
59K
|
2
|
|
ASX - By Stock
|
AVZ |
Re:
Locke Extension
|
|
WelshBuffett
|
150 |
74K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
150
|
74K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
486K |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
1.6K
|
486K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
31K |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
115
|
31K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
486K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.6K
|
486K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
486K |
0 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.6K
|
486K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
486K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.6K
|
486K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
31K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
31K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
31K |
6 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
31K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
31K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
31K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
31K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
31K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
31K |
6 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
31K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
31K |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
31K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
31K |
6 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
31K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
The Final Countdown
|
|
WelshBuffett
|
225 |
59K |
1 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
225
|
59K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
4 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
2 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
1 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
0 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
0 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
0
|
|
ASX - By Stock
|
SHP |
Re:
Ann: Ohmgebirge Scoping Study Conference Call Details
|
|
WelshBuffett
|
47 |
16K |
0 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
47
|
16K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
1 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
3 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
SHP |
Re:
Ann: Ohmgebirge Scoping Study Conference Call Details
|
|
WelshBuffett
|
47 |
16K |
3 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
47
|
16K
|
3
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
WelshBuffett
|
331 |
153K |
9 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
331
|
153K
|
9
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
WelshBuffett
|
331 |
153K |
1 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
331
|
153K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.3M |
7 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
13K
|
6.3M
|
7
|
|